18-62161173-C-T
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_176787.5(PIGN):c.181G>A(p.Glu61Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000136 in 1,613,410 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_176787.5 missense
Scores
Clinical Significance
Conservation
Publications
- multiple congenital anomalies-hypotonia-seizures syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, Orphanet, ClinGen, PanelApp Australia
- Fryns syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_176787.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PIGN | NM_176787.5 | MANE Select | c.181G>A | p.Glu61Lys | missense | Exon 4 of 31 | NP_789744.1 | ||
| PIGN | NM_001438896.1 | c.181G>A | p.Glu61Lys | missense | Exon 4 of 32 | NP_001425825.1 | |||
| PIGN | NM_012327.6 | c.181G>A | p.Glu61Lys | missense | Exon 3 of 30 | NP_036459.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PIGN | ENST00000640252.2 | TSL:1 MANE Select | c.181G>A | p.Glu61Lys | missense | Exon 4 of 31 | ENSP00000492233.1 | ||
| PIGN | ENST00000400334.7 | TSL:1 | c.181G>A | p.Glu61Lys | missense | Exon 3 of 30 | ENSP00000383188.2 | ||
| PIGN | ENST00000638424.1 | TSL:5 | n.181G>A | non_coding_transcript_exon | Exon 2 of 29 | ENSP00000491963.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152146Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000402 AC: 1AN: 248942 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461264Hom.: 0 Cov.: 30 AF XY: 0.0000110 AC XY: 8AN XY: 726872 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152146Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74328 show subpopulations
ClinVar
Submissions by phenotype
Multiple congenital anomalies-hypotonia-seizures syndrome 1 Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 61 of the PIGN protein (p.Glu61Lys). This variant is present in population databases (no rsID available, gnomAD 0.004%). This variant has not been reported in the literature in individuals affected with PIGN-related conditions. ClinVar contains an entry for this variant (Variation ID: 862222). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The lysine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at